OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap

Roughly half of 2026 contracts came from new customers.

Rhea-AI Summary

OneMedNet (ONMD) reported approximately $18.76 million in year-to-date contracted bookings as of November 6, 2026, alongside a commercial growth recap. Contracted demand stands at nearly 14 times full-year 2025 bookings. Of the bookings reported, $1.388 million has been converted to revenue through September 30, 2026.

The “OneMedNet by the Numbers” recap draws on the company’s November 6 financial outlook, earlier public disclosures and SEC filings. The bookings and revenue-conversion figures cover different reporting cutoffs.

3 points · 1 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 0 points

How the balance works

Positive

• Major pointApproximately $18.76 million in year-to-date bookings as of November 6, 2026, nearly 14 times full-year 2025 bookings. 63% of market cap
• Minor point$1.388 million of reported bookings converted to revenue through September 30, 2026.
• Minor pointRoughly half of 2026 contracts came from new customers.

Negative

• None.

News Explained

OneMedNet says roughly half of its 2026 contracts came from new customers, adding a customer-mix detail to its commercial growth recap.

Key Figures

Year-to-date contracted bookings: $18.76 million Bookings converted to revenue: $1.388 million Contracted demand vs. 2025 bookings: Nearly 14 times

Year-to-date contracted bookings

$18.76 million

As of November 6, 2026

Bookings converted to revenue

$1.388 million

Through September 30, 2026

Contracted demand vs. 2025 bookings

Nearly 14 times

Compared with full-year 2025 bookings

Key Terms

real-world data, de-identified, multi-modal data

3 terms

real-world data technical

"regulatory decision-grade, AI-driven Real-World Data (RWD)"

Real-world data consists of information collected from everyday sources outside of controlled experiments or official reports, such as patient records, insurance claims, or wearable device readings. For investors, it provides a more complete picture of how products and services perform in actual use, helping them make better-informed decisions based on how things work in real life rather than just in theory or controlled settings.

de-identified technical

"datasets that include de-identified medical imaging"

Data labeled as de-identified has had names and other direct personal details removed or masked so individual people cannot be readily recognized; think of it like blurring faces and removing name tags from a photo. For investors, de-identification matters because it reduces legal and privacy risk, can change how valuable or usable the data is for research or product development, and affects regulatory compliance and potential liabilities.

multi-modal data technical

"Our platform allows us to deliver multi-modal data"

Multi-modal data is information that combines different kinds of inputs — for example text, numbers, images, audio, or sensor readings — so a system can use several “senses” at once. For investors, it matters because combining these sources often gives a clearer, more complete picture of a company’s performance, product quality, or market trends (like seeing and hearing a situation instead of only reading about it), which can improve forecasting, risk assessment, and comparisons among competitors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Contracted Demand Now Stands at Nearly 14 Times Full-Year 2025 Bookings, with Roughly Half of 2026 Contracts from New Customers

MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that bookings reached approximately $18.76 million year-to-date as of November 6, 2026, of which $1.388 million has been converted to revenue through September 30, 2026.

The announcement accompanies the release of “OneMedNet by the Numbers,” a growth recap summarizing the Company’s commercial and operational trajectory, drawn from the Company’s November 6, 2026 financial outlook, prior public disclosures, and SEC filings. The full infographic is available at https://www.onemednet.com/investors#by-the-numbers.

“Our strategy is working,” said Aaron Green, President & CEO of OneMedNet. “We have focused on building strong relationships with industry leaders that already hold contracts across pharma and foundational AI, streamlining the contracting process and reducing our time to booking. Our platform allows us to deliver multi-modal data at the scale these customers require. The numbers in this recap are the result of our execution.”

About OneMedNet Corporation

OneMedNet Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Learn more at www.onemednet.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding our preliminary results for the third quarter of 2026, our revenue outlook for the fourth quarter of 2026, our ability to convert bookings into recognized revenue, the timing of revenue recognition, and statements generally about our products, plans and strategies. Bookings are an operational metric, and there can be no assurance that bookings will convert into recognized revenue in the amounts or on the timeline anticipated.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include but are not limited to our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:

Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f441ddbf-5efe-4cc0-8eae-f9c972274f64

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much has OneMedNet reported in 2026 bookings and converted revenue?

OneMedNet reported approximately $18.76 million in year-to-date bookings as of November 6, 2026, of which $1.388 million has been converted to revenue through September 30, 2026. The two figures have different reporting cutoffs.